Citius Pharmaceuticals, Inc. (CTXR) vs Pulsenmore Ltd. Ordinary Shares (PLSM)
A side-by-side comparison of Citius Pharmaceuticals, Inc. and Pulsenmore Ltd. Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTXR
Citius Pharmaceuticals, Inc.
$0.48HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PLSM
Pulsenmore Ltd. Ordinary Shares
$2.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CTXR vs PLSM
growth of $100 · dividends reinvested · last 1yCTXR -35.9% (-35.9%/yr)PLSM -70.0% (-70.0%/yr)CTXR compounded faster over this window
CTXR PLSM
CTXR vs PLSM: by the numbers
- •PLSM is the larger company ($14M vs $13M market cap).
- •Both run net losses; PLSM's is the smaller (-39.61% vs -651.27% net margin).
Metrics side by side
Valuation
| Metric | CTXR | PLSM |
|---|---|---|
| P/S ratio | 1.86 | N/A |
| P/B ratio | 0.20 | 0.86 |
Profitability
| Metric | CTXR | PLSM |
|---|---|---|
| Gross margin | 0.00% | 84.15% |
| Operating margin | 0.00% | -30.39% |
| Net margin | -651.27% | -39.61% |
| ROE | -69.47% | -19.08% |
| ROIC | -67.62% | -13.15% |
Growth (annualized)
| Metric | CTXR | PLSM |
|---|---|---|
| Total return CAGR (5Y) | -60.04% | N/A |
Go deeper
Dig into the metrics
Citius Pharmaceuticals ROEPulsenmore Ltd. Ordinary Shares ROECitius Pharmaceuticals operating marginPulsenmore Ltd. Ordinary Shares operating marginCitius Pharmaceuticals revenue growthPulsenmore Ltd. Ordinary Shares revenue growthCitius Pharmaceuticals free cash flowPulsenmore Ltd. Ordinary Shares free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.